Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty.
D015068:17-Ketosteroids / Q000652:urine; D000312:Adrenal Hyperplasia, Congenital / Q000150:complications / Q000188:drug therapy*; D000726:Androgen Antagonists; D001827:Body Height; D002648:Child; D002675:Child, Preschool; D003534:Cyproterone / Q000627:therapeutic use; D005640:Follicle Stimulating Hormone / Q000097:blood; D006065:Gonadotropins, Pituitary / Q000652:urine; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D011245:Pregnadienes / Q000627:therapeutic use*; D011629:Puberty, Precocious / Q000150:complications / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood
D015068:17-Ketosteroids; D000726:Androgen Antagonists; D006065:Gonadotropins, Pituitary; D011245:Pregnadienes; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D003534:Cyproterone